# Efficacy and Safety of Simultaneous Integrated Boost Radiotherapy in HR/VHR Prostate Cancer With EPLNI

> **NCT07693075** · PHASE2 · RECRUITING · sponsor: **Ain Shams University** · enrollment: 30 (estimated)

## Conditions studied

- Prostate Cancer Patients Treated by Radiotherapy

## Interventions

- **RADIATION:** Simultaneous Integrated Boost Volumetric Modulated Arc Therapy (SIB-VMAT)

## Key facts

- **NCT ID:** NCT07693075
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-01
- **Primary completion:** 2026-09-01
- **Final completion:** 2026-11-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07693075

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07693075, "Efficacy and Safety of Simultaneous Integrated Boost Radiotherapy in HR/VHR Prostate Cancer With EPLNI". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07693075. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*